Robert Vidal is a partner specialising in EU and UK competition law. He regularly advises companies on compliance and has built up significant behavioural experience successfully defending companies during investigations run by the CMA and European Commission in the life sciences sector.
He submitted the first successful appeal to the Competition Appeal Tribunal and built up notable experience on the interplay between intellectual property rights and competition law and regularly advises on commercial and licensing agreements. He has extensive experience of M&A work and has submitted a wide variety of merger notifications to numerous competition authorities including various mergers in the life science and technology sector.
Robert has carried out advocacy before the Competition Appeal Tribunal, submitted complaints to the CMA and European Commission, and been involved in many high profile and innovative cases before the ECJ, the General Court and the High Court including:
- an Appeal to the ECJ against the European Commission’s decision to impose total fines of €146m in relation to “reverse payment” settlement agreements in the pharmaceutical sector;
- a High Court damages claim against Reckitt Benckiser for “abuse of dominance” in relation to well-known heartburn medicine Gaviscon; and
- advising on various High Court disputes involving the application of competition law and the concept of “FRAND” to various patent infringement disputes.
Robert has an LLB (European Legal Studies) from Durham University.